Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1990 Jul;43(7):560–562. doi: 10.1136/jcp.43.7.560

Plasma fibronectin concentrations in patients with human immunodeficiency virus infection.

D Torre 1, M Issi 1, C Sampietro 1, G P Fiori 1, G Chelazzi 1, G Ferraro 1
PMCID: PMC502580  PMID: 2380404

Abstract

Plasma fibronectin (PFN) concentrations were assessed in 21 patients with AIDS, in seven with AIDS-related complex (ARC), in 17 asymptomatic seropositive patients, and in 36 age and sex matched healthy control subjects. A single radial immunodiffusion technique was used to determine PFN concentration. A significant decrease in PFN concentrations was observed in patients with ARC and AIDS (especially in those patients with Pneumocystis carinii pneumonitis). On the other hand, normal PFN concentrations were observed in asymptomatic seropositive patients. The determination of PFN concentration in patients with AIDS and ARC may contribute to the diagnosis of such patients.

Full text

PDF
560

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baughn R. E., McNeely M. C., Jorizzo J. L., Musher D. M. Characterization of the antigenic determinants and host components in immune complexes from patients with secondary syphilis. J Immunol. 1986 Feb 15;136(4):1406–1414. [PubMed] [Google Scholar]
  2. Carsons S., Lavietes B. B., Diamond H. S. Factors influencing the incorporation of fibronectin into synovial fluid cryoprotein. J Lab Clin Med. 1983 Nov;102(5):722–731. [PubMed] [Google Scholar]
  3. Jarstrand C., Ahlgren T., Berghem L. Fibronectin increases the motility, phagocytosis and NBT (nitroblue tetrazolium)-reduction of granulocytes. J Clin Lab Immunol. 1982 May;8(1):59–63. [PubMed] [Google Scholar]
  4. Julkunen I., Hautanen A., Keski-Oja J. Interaction of viral envelope glycoproteins with fibronectin. Infect Immun. 1983 Jun;40(3):876–881. doi: 10.1128/iai.40.3.876-881.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kuusela P. Fibronectin binds to Staphylococcus aureus. Nature. 1978 Dec 14;276(5689):718–720. doi: 10.1038/276718a0. [DOI] [PubMed] [Google Scholar]
  6. Lazzarin A., Uberti Foppa C., Galli M., Mantovani A., Poli G., Franzetti F., Nóvati R. Impairment of polymorphonuclear leucocyte function in patients with acquired immunodeficiency syndrome and with lymphadenopathy syndrome. Clin Exp Immunol. 1986 Jul;65(1):105–111. [PMC free article] [PubMed] [Google Scholar]
  7. Mosher D. F. Fibronectin. Prog Hemost Thromb. 1980;5:111–151. [PubMed] [Google Scholar]
  8. Mosher D. F. Physiology of fibronectin. Annu Rev Med. 1984;35:561–575. doi: 10.1146/annurev.me.35.020184.003021. [DOI] [PubMed] [Google Scholar]
  9. Myhre E. B., Kuusela P. Binding of human fibronectin to group A, C, and G streptococci. Infect Immun. 1983 Apr;40(1):29–34. doi: 10.1128/iai.40.1.29-34.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ogden D. M., Fischer H. E., Liu F. J., Rios A., Lichtiger B. Plasma fibronectin values in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Am J Clin Pathol. 1988 Sep;90(3):293–296. doi: 10.1093/ajcp/90.3.293. [DOI] [PubMed] [Google Scholar]
  11. Poli G., Bottazzi B., Acero R., Bersani L., Rossi V., Introna M., Lazzarin A., Galli M., Mantovani A. Monocyte function in intravenous drug abusers with lymphadenopathy syndrome and in patients with acquired immunodeficiency syndrome: selective impairment of chemotaxis. Clin Exp Immunol. 1985 Oct;62(1):136–142. [PMC free article] [PubMed] [Google Scholar]
  12. Polsky B., Gold J. W., Whimbey E., Dryjanski J., Brown A. E., Schiffman G., Armstrong D. Bacterial pneumonia in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1986 Jan;104(1):38–41. doi: 10.7326/0003-4819-104-1-38. [DOI] [PubMed] [Google Scholar]
  13. Proctor R. A. Fibronectin: an enhancer of phagocyte function. Rev Infect Dis. 1987 Jul-Aug;9 (Suppl 4):S412–S419. doi: 10.1093/clinids/9.supplement_4.s412. [DOI] [PubMed] [Google Scholar]
  14. Proctor R. A., Textor J. A., Vann J. M., Mosher D. F. Role of fibronectin in human monocyte and macrophage bactericidal activity. Infect Immun. 1985 Mar;47(3):629–637. doi: 10.1128/iai.47.3.629-637.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ruoslahti E., Engvall E., Hayman E. G. Fibronectin: current concepts of its structure and functions. Coll Relat Res. 1981;1(1):95–128. doi: 10.1016/s0174-173x(80)80011-2. [DOI] [PubMed] [Google Scholar]
  16. Skerl K. G., Calderone R. A., Segal E., Sreevalsan T., Scheld W. M. In vitro binding of Candida albicans yeast cells to human fibronectin. Can J Microbiol. 1984 Feb;30(2):221–227. doi: 10.1139/m84-033. [DOI] [PubMed] [Google Scholar]
  17. Smith P. D., Ohura K., Masur H., Lane H. C., Fauci A. S., Wahl S. M. Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis. J Clin Invest. 1984 Dec;74(6):2121–2128. doi: 10.1172/JCI111637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wyler D. J. Fibronectin in parasitic diseases. Rev Infect Dis. 1987 Jul-Aug;9 (Suppl 4):S391–S399. doi: 10.1093/clinids/9.supplement_4.s391. [DOI] [PubMed] [Google Scholar]
  19. Wyler D. J. Fibronectin in parasitic diseases. Rev Infect Dis. 1987 Jul-Aug;9 (Suppl 4):S391–S399. doi: 10.1093/clinids/9.supplement_4.s391. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES